New tariffs: What US based MedTech & Diagnostics Companies must know

Published on July 4, 2025

New and reinstated US tariffs are creating cost pressure and disruption across the healthcare, MedTech, and diagnostics sectors. For US companies, the time to respond is now.

In this focused webinar, we’ll break down the latest tariff changes and what they mean for your supply chain, pricing strategy, and commercial operations. Get clear, actionable insights to help you protect margins, adapt sourcing, and stay competitive.

Key takeaways:

  • What the new tariffs mean for your business
  • How to manage cost increases and supply chain risks
  • Strategic moves to maintain pricing and market access

Who should attend:
U.S.-based leaders in supply chain, market access, pricing, procurement, and commercial strategy across medical devices, diagnostics, and broader healthcare.

 

* We also offer a webinar tailored for EU companies to learn how global trade…

US

Continue reading on website
Other news

The future of recurring revenue models: from one-time sales to lifelong customers

July 3, 2025
Recurring revenue models are becoming increasingly attractive to businesses across industries, promising financial stability, enhanced customer retention, and scalable growth. Once dominated by Technology, Media and Energy sectors, these models are now gaining traction in traditional industrial and consumer businesses, as companies recognize their potential to transform revenue streams.In today’s

Global tariffs: What European Healthcare & MedTech companies need to watch out for

July 4, 2025
EU healthcare and medtech companies are being hit by new global tariffs, including from the US. These measures are raising costs, complicating sourcing, and pressuring margins. This webinar will unpack the key trade shifts and what they mean for your operations and growth plans. Learn how to adapt your strategy, manage risk, and stay resilient in a volatile trade environment. Key takeaways: Which